493 related articles for article (PubMed ID: 19420084)
1. Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection.
Rockx B; Baas T; Zornetzer GA; Haagmans B; Sheahan T; Frieman M; Dyer MD; Teal TH; Proll S; van den Brand J; Baric R; Katze MG
J Virol; 2009 Jul; 83(14):7062-74. PubMed ID: 19420084
[TBL] [Abstract][Full Text] [Related]
2. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
[TBL] [Abstract][Full Text] [Related]
3. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice.
Nagata N; Iwata N; Hasegawa H; Fukushi S; Harashima A; Sato Y; Saijo M; Taguchi F; Morikawa S; Sata T
Am J Pathol; 2008 Jun; 172(6):1625-37. PubMed ID: 18467696
[TBL] [Abstract][Full Text] [Related]
4. Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice.
Rockx B; Sheahan T; Donaldson E; Harkema J; Sims A; Heise M; Pickles R; Cameron M; Kelvin D; Baric R
J Virol; 2007 Jul; 81(14):7410-23. PubMed ID: 17507479
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.
Rockx B; Corti D; Donaldson E; Sheahan T; Stadler K; Lanzavecchia A; Baric R
J Virol; 2008 Apr; 82(7):3220-35. PubMed ID: 18199635
[TBL] [Abstract][Full Text] [Related]
6. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.
Du L; Zhao G; He Y; Guo Y; Zheng BJ; Jiang S; Zhou Y
Vaccine; 2007 Apr; 25(15):2832-8. PubMed ID: 17092615
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model.
Ishii K; Hasegawa H; Nagata N; Ami Y; Fukushi S; Taguchi F; Tsunetsugu-Yokota Y
Microbiol Immunol; 2009 Feb; 53(2):75-82. PubMed ID: 19291090
[TBL] [Abstract][Full Text] [Related]
8. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.
Sheahan T; Morrison TE; Funkhouser W; Uematsu S; Akira S; Baric RS; Heise MT
PLoS Pathog; 2008 Dec; 4(12):e1000240. PubMed ID: 19079579
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants.
Sui J; Li W; Roberts A; Matthews LJ; Murakami A; Vogel L; Wong SK; Subbarao K; Farzan M; Marasco WA
J Virol; 2005 May; 79(10):5900-6. PubMed ID: 15857975
[TBL] [Abstract][Full Text] [Related]
10. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants.
Deming D; Sheahan T; Heise M; Yount B; Davis N; Sims A; Suthar M; Harkema J; Whitmore A; Pickles R; West A; Donaldson E; Curtis K; Johnston R; Baric R
PLoS Med; 2006 Dec; 3(12):e525. PubMed ID: 17194199
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
[TBL] [Abstract][Full Text] [Related]
12. Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model.
Miyoshi-Akiyama T; Ishida I; Fukushi M; Yamaguchi K; Matsuoka Y; Ishihara T; Tsukahara M; Hatakeyama S; Itoh N; Morisawa A; Yoshinaka Y; Yamamoto N; Lianfeng Z; Chuan Q; Kirikae T; Sasazuki T
J Infect Dis; 2011 Jun; 203(11):1574-81. PubMed ID: 21592986
[TBL] [Abstract][Full Text] [Related]
13. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ
J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835
[TBL] [Abstract][Full Text] [Related]
14. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
[TBL] [Abstract][Full Text] [Related]
15. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.
Liu L; Wei Q; Lin Q; Fang J; Wang H; Kwok H; Tang H; Nishiura K; Peng J; Tan Z; Wu T; Cheung KW; Chan KH; Alvarez X; Qin C; Lackner A; Perlman S; Yuen KY; Chen Z
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830861
[TBL] [Abstract][Full Text] [Related]
16. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
[TBL] [Abstract][Full Text] [Related]
17. Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies.
Fang YT; Lin CF; Liao PC; Kuo YM; Wang S; Yeh TM; Shieh CC; Su IJ; Lei HY; Lin YS
Mol Immunol; 2010 Feb; 47(5):1000-9. PubMed ID: 20015551
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues.
Baas T; Taubenberger JK; Chong PY; Chui P; Katze MG
J Interferon Cytokine Res; 2006 May; 26(5):309-17. PubMed ID: 16689659
[TBL] [Abstract][Full Text] [Related]
19. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.
Frieman M; Yount B; Agnihothram S; Page C; Donaldson E; Roberts A; Vogel L; Woodruff B; Scorpio D; Subbarao K; Baric RS
J Virol; 2012 Jan; 86(2):884-97. PubMed ID: 22072787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
